Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
SillaJen history
SillaJen company history timeline
2008.08 Jennerex initiated Pexa-Vec Phase 2a clinical trial (HEP007)
2014.03 SillaJen acquired Jennerex, Inc., the global leader in oncolytic immunotherapeutics Jennerex was an early leader in the oncolytic virus field.
In January 2016, SillaJen announces first patient randomized in its global Phase 3 trial for Pexa-Vec in Advanced Liver Cancer.
2017.08 Collaboration with National Cancer Institute of the US for developing Pexa-Vec in combination with immune checkpoint inhibitors
2018.03 Stretched out additional vaccinia virus related patents in 13 European territories
SEP 2020 Neoadjuvant Study in Prostate Cancer, Multi-Center trials including Royal Melbourne Hospital in VIC, Australia ; Approved in HREC and plan to notify TGA
JUL 2021 Changed the largest shareholder to M2N Co., Ltd.
Rate SillaJen's efforts to communicate its history to employees.
SillaJen jobs
Do you work at SillaJen?
Is SillaJen's vision a big part of strategic planning?
SillaJen history FAQs
Zippia gives an in-depth look into the details of SillaJen, including salaries, political affiliations, employee data, and more, in order to inform job seekers about SillaJen. The employee data is based on information from people who have self-reported their past or current employments at SillaJen. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by SillaJen. The data presented on this page does not represent the view of SillaJen and its employees or that of Zippia.
SillaJen may also be known as or be related to Jennerex , Inc, SillaJen, SillaJen, Inc., Sillajen Inc. and Sillajen Usa, Inc.